Skip to main content
Premium Trial:

Request an Annual Quote

Eight US Institutions Awarded $350M for Biodefense RCEs

NEW YORK, Sept. 5 (GenomeWeb News) - US Health and Human Services secretary Tommy Thompson announced yesterday that grants totaling $350 million over five years had been awarded to establish eight Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases at institutions across the country.

 

The National Institute of Allergy and Infectious Diseases will administer the grants, which were awarded to: DukeUniversity, Harvard Medical School, New York State Department of Health, University of Chicago, University of Maryland, University of Texas Medical Branch, University of Washington, and WashingtonUniversity in St. Louis.

 

The grants stipulate that the institutions use genomics, proteomics, and bioinformatics, among other biological methods, to develop methods of dealing with agents of potential bioterrorist attacks - such as anthrax and smallpox - and emerging novel diseases, such as SARS. The institutions must also provide facilities and services in the case of a national biodefense emergency.

 

Proteomics will likely play a large role at the RCEs, as reported in ProteoMonitor last month.

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.